B. Braun Transforms its Structure in Spain to Grow Thanks to Digital Business

B. Braun undertakes major changes in its management and hiring policy. The appointment in March of Christoph Müller as the new president of the company’s board of directors in Spain , replacing Anna Maria Braun, executive director of the multinational, has been accompanied by the incorporation and promotion of young talent to management positions. Müller, born in 1981, had already been serving as CEO in the same country since January 2023.

This path was paved in November, with the signing of a new human resources director, Andrea Sellés, from Boehringer Ingelheim, a position previously held by Christian Navarro. Together with the now president of the company B Braun Medical, B. Braun also appointed the financial director, Gabriel Sabaté, and the general director of sales and marketing, Alberto Sábado, as directors in March .

The leap to digitalization should serve the German group to boost its growth. Sources from B. Braun advance that the group had a turnover of 615 million euros in Spain last year, 7% more than in 2022 . The company’s CEO indicates that in 2024 they expect to grow between 5% and 7% in sales, both in the local market and in the international export market.

Müller said that the company he runs in Spain is undertaking an in-depth corporate transformation around the world to become a medical company with a strong technological component and complement its portfolio of services and products with digital solutions. The German manager, who has spent his entire career in the multinational, points out that the entry of Anna Maria Braun, the sixth generation of the founding family, has meant a boost to the generational change in the management of the company’s subsidiaries.

B. Braun expects to grow in Spain between 5% and 7%, a figure close to the increase experienced in 2023 compared to 2022, when it reached 615 million euros in sales

The CEO of B. Braun in Spain reports that the incorporation of new profiles is aimed, first, at the internal digital transformation, at implementing changes in the work processes of its employees, and then at developing a portfolio of new technological solutions. For your customers. Some examples of these new products are digital microscopes for the field of neurosurgery and a new offering in the area of ​​medical imaging.

Among these new profiles, some have joined the ranks of the digital hub that B. Braun opened last January in Barcelona: they are software engineers or front-end and back-end programmers . In the clinical field, the company has also hired personnel to consolidate capabilities in the area of ​​cybersecurity .

The commitment of B. Braun’s Spanish management is to support decision-making with data. That is, about the exploitation of open data from the Spanish health system, but also the data generated by the products they market. Müller anticipates that this area will have a relevant role in the future when it comes to guaranteeing the efficiency of processes, both those of the company itself and those of its clients, but does not anticipate percentages of the weight that this business will have .

The company’s other great challenge is sustainability, which has resulted in the introduction of green energy in all its plants, the investment in solar panels in its logistics center in Santa Oliva (Tarragona) and in Rubí, its headquarters, and systems to reduce your water consumption.

__

(Featured image by Herney via Pixabay)

DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published in PlantaDoce. A third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us